Exosomes for Clinical Use —
Built on Data, Consistency, and Integrity
Your patients count on you to select products backed by evidence and transparent documentation. We provide clinician-grade extracellular vesicles with verified testing, clear data, and options that match real-world case needs.
Immediate Access to Documentation
Two Biologic Sources by Design
Different clinical goals benefit from different vesicle profiles. We offer two options so you can align biology with patient needs.
- Plasma-Derived Vesicles: Selected for broad signaling profiles that support systemic cellular communication.
- Wharton’s Jelly–Derived Vesicles: Selected for localized tissue applications where regenerative support is desired.
- Choice with Clarity: Both options are documented with third-party data so selection is driven by evidence, not assumptions.
Why Lyophilized Matters
Stability and structural integrity are central to consistent performance. Lyophilization supports reliable handling and reduces temperature-related risk.
- Preserves vesicle structure and signaling cargo
- Minimizes freeze–thaw variability during transport
- Enables controlled reconstitution at point of use
- Supports consistency from vial to vial
Exosome Information
Not all exosomes are created equal. Our lab uses advanced processing methods to ensure purity, consistency, and potency, so clinicians and patients can rely on a safer, more effective product. Many practices have already made the switch—find out why by speaking directly with our team.
Request a Consultation Call
Fill out the form below, and one of our clinical specialists will contact you to discuss documentation, clinical data, and how our exosomes can support your practice.
*We will contact you directly to discuss your questions. Your information is confidential and used only for this purpose.
Intact vs “Live” — Getting the Science Right
Exosomes are not living cells. They are bioactive communication vesicles. The priority is structural integrity and preserved signaling potential — not “viability.”
- Focus on intact membranes, surface markers, and cargo
- Integrity influences interaction with target cells
- Proper preservation and handling protect functional capacity
- Clear terminology reduces clinical and regulatory confusion
Transparency You Can Verify
We don’t ask you to take our word for it. We provide documentation that stands up to scrutiny.
- Third-party characterization reports
- Particle count validation
- Sterility and endotoxin testing
- Batch-linked Certificates of Analysis
Exosome Vendor Standards — Verified and Transparent
When selecting exosomes for clinical use, it’s critical to work with a vendor that meets rigorous quality and documentation standards.
Unlike other suppliers, we provide:
- Independent, Third-Party Validation: Each batch comes with verified particle counts, characterization data, and a Certificate of Analysis (COA).
- Transparent Preservation & Handling: Lyophilization protocols and handling instructions are fully documented to ensure structural integrity and consistent signaling potential.
- Comprehensive Characterization: Membrane integrity, surface markers, and cargo are fully analyzed and reported to support reproducible clinical outcomes.
- Scientific Accuracy: Terminology is precise—exosomes are bioactive vesicles, not living cells. No misleading “live exosome” claims.
- Responsible Sourcing: Every source is documented and ethically managed, ensuring traceability and accountability.
Talk with Our Team
Our mission is simple: give clinicians the data they need and patients the care they deserve.
- Discuss source selection for your use cases
- Review testing and documentation
- Align on logistics and onboarding